IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Bernardi, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.273
EU - Europa 3.070
AS - Asia 1.841
SA - Sud America 21
OC - Oceania 13
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.227
IT - Italia 727
CN - Cina 611
PL - Polonia 610
SG - Singapore 543
UA - Ucraina 490
HK - Hong Kong 382
DE - Germania 333
FI - Finlandia 229
RU - Federazione Russa 170
TR - Turchia 135
IE - Irlanda 125
GB - Regno Unito 109
SE - Svezia 67
IN - India 64
FR - Francia 62
CZ - Repubblica Ceca 45
CA - Canada 35
BE - Belgio 30
VN - Vietnam 19
ID - Indonesia 13
NL - Olanda 13
AU - Australia 12
DK - Danimarca 12
AT - Austria 9
BR - Brasile 8
JP - Giappone 8
KR - Corea 8
TH - Thailandia 8
EG - Egitto 7
GR - Grecia 7
IL - Israele 7
BD - Bangladesh 6
LK - Sri Lanka 6
PT - Portogallo 6
BO - Bolivia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
ES - Italia 4
IR - Iran 4
CO - Colombia 3
CU - Cuba 3
EU - Europa 3
HR - Croazia 3
JO - Giordania 3
LV - Lettonia 3
MX - Messico 3
PA - Panama 3
RO - Romania 3
AR - Argentina 2
CH - Svizzera 2
EE - Estonia 2
HU - Ungheria 2
IQ - Iraq 2
KG - Kirghizistan 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MS - Montserrat 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 10.233
Salva come PNG Salva come JPEG
Città #
Fairfield 710
Warsaw 602
Woodbridge 457
Singapore 429
Ashburn 423
Hong Kong 381
Chandler 372
Jacksonville 354
Houston 296
Seattle 280
Wilmington 272
Ann Arbor 270
Cambridge 263
Princeton 219
Brescia 211
New York 198
Helsinki 184
Beijing 135
Dublin 123
Istanbul 120
Shanghai 90
Nanjing 70
Boardman 68
Moscow 59
Milan 51
Des Moines 48
San Diego 47
Dearborn 46
Brno 41
Nanchang 37
Pune 36
Munich 33
Changsha 32
Brussels 30
Los Angeles 30
Jinan 29
Shenyang 27
Tianjin 26
Romola 21
Nuremberg 20
San Francisco 20
Toronto 20
Jiaxing 19
London 19
Dong Ket 18
Rome 18
Ningbo 17
Genoa 16
Hebei 16
Verona 16
Kocaeli 13
Barlassina 12
Falkenstein 12
Hangzhou 12
Helsingør 12
Jakarta 11
Lappeenranta 11
Zhengzhou 11
Darfo 10
Guangzhou 10
Norwalk 10
Bologna 9
Kunming 9
Santa Clara 9
Bergamo 8
Bosio 8
Gorlago 7
Newark 7
Turin 7
Athens 6
Brooklyn 6
Colombo 6
Florence 6
Phoenix 6
São Paulo 6
Taizhou 6
Wroclaw 6
Ancona 5
Cairo 5
Chiswick 5
Haikou 5
Hounslow 5
Ottawa 5
Pavia 5
Redwood City 5
Amsterdam 4
Augusta 4
Bangkok 4
Battipaglia 4
Como 4
Frankfurt am Main 4
Melbourne 4
Orange 4
Padova 4
Pescara 4
Prescot 4
Tokyo 4
Vienna 4
Wandsworth 4
Alzano Lombardo 3
Totale 7.654
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 272
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 243
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 238
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 225
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 200
Zebrafish disease models in hematology: Highlights on biological and translational impact 175
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 141
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 137
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 137
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 133
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 133
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 132
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 132
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 131
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 128
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 127
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 121
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 118
Alterations of AQP2 expression in trigeminal ganglia in a murine inflammation model 117
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 116
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 114
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 107
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 105
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 105
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 104
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 104
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 103
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 103
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 103
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 102
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 100
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 100
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 100
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 97
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 95
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 95
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 94
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 92
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 89
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor 88
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome 87
Advances in CMV Management: A Single Center Real-Life Experience 87
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 85
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 84
Extracellular Vesicles: From Biomarkers to Therapeutic Tools 84
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 83
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 83
PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY. 82
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 80
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 80
EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD). 79
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 79
Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia 79
ACHIEVEMENT OF COMPLETE REMISSION WITH PONATINIB THERAPY FOR PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A CASE REPORT. 78
AZACITIDINE (AZA) FOR RELAPSED HIGH RISK MYELODYSPLASIC SYNDROME AFTER INTRABONE CORD BLOOD TRANSPLANTATION: A CASE REPORT. 78
THE PYROSEQUENCING: A NEW PROMISING APPROACH TO PERFORM HLA TYPING AND SELECT THE STEM CELL DONOR IN A QUICKLY, SIMPLE AND ACCURATE WAY 77
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 77
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 77
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 76
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC) 75
PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 73
Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message? 73
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 72
BRENTUXIMAB SALVAGE THERAPY IN HODGKIN LYMPHOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE. 72
EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO) 72
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 72
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO EVALUATE THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION 70
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 70
MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION. 69
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 69
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 68
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 67
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 65
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 65
PROFILE OF TOLL-LIKE RECEPTORS ON MONOCYTES AND LYMPHOCYTES IN RELATION TO INFECTIOUS COMPLICATIONS AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANTATION. 64
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 64
Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs 63
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 63
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 62
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 61
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 61
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 59
Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood? 58
HLA-TYPING BY PYROSEQUENCING TECHNOLOGY: A NEW PROMISING QUICKLY AND ACCURATE APPROACH WITHOUT PHASE AMBIGUITIES. 57
FAILURE TO REPLICATE THE ASSOCIATION OF UROMODULIN GENE VARIANT RS 13333226 WITH HYPERTENSION IN A GENERAL POPULATION STUDY 56
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 56
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? 55
Co-isolation and analysis of extracellular vesicle (EV)-associated DNA and cell free DNA (cfDNA) to improve the diagnostic and prognostic value of circulating BRAF V600E in metastatic melanoma patients 55
dsDNA from extracellular vesicles (EVs) in adult AML 54
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 54
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients 53
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 53
Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report 52
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 51
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS AND STIMULATORY CYTOKINES ON THE IN VITRO GROWTH OF UCB HEMATOPOIETIC PROGENITOR CELLS. 51
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 51
Abstract A27: European Network NGS-PTL preliminary data: Whole exome sequencing identifies mutations of ALDH2, RETSAT, HSPG2, CHPF and other metabolic genes as a novel functional category in acute myeloid leukemia 51
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 51
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 50
Abstract 90: A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 50
Totale 9.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020727 0 0 0 0 0 0 0 0 205 292 95 135
2020/20211.914 45 148 101 269 79 230 70 214 161 326 168 103
2021/20221.059 89 100 44 63 39 75 52 73 63 143 75 243
2022/20231.112 154 48 45 84 113 229 8 121 165 16 64 65
2023/20241.539 71 32 121 86 92 368 85 77 260 26 41 280
2024/20251.676 61 77 50 390 291 279 236 167 125 0 0 0
Totale 10.568